HUT71310A - Methods and preparations for suppression of proliferative response and induction of tolerance wita polymorphic class ii mhc allopeptides - Google Patents
Methods and preparations for suppression of proliferative response and induction of tolerance wita polymorphic class ii mhc allopeptidesInfo
- Publication number
- HUT71310A HUT71310A HU9403006A HU9403006A HUT71310A HU T71310 A HUT71310 A HU T71310A HU 9403006 A HU9403006 A HU 9403006A HU 9403006 A HU9403006 A HU 9403006A HU T71310 A HUT71310 A HU T71310A
- Authority
- HU
- Hungary
- Prior art keywords
- mammal
- methods
- nonself
- wita
- suppression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87128992A | 1992-04-20 | 1992-04-20 | |
US96177992A | 1992-10-15 | 1992-10-15 | |
US97773792A | 1992-11-13 | 1992-11-13 | |
US08/027,127 US5593698A (en) | 1990-10-31 | 1993-03-05 | Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9403006D0 HU9403006D0 (en) | 1994-12-28 |
HUT71310A true HUT71310A (en) | 1995-11-28 |
Family
ID=27487557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9403006A HUT71310A (en) | 1992-04-20 | 1993-04-20 | Methods and preparations for suppression of proliferative response and induction of tolerance wita polymorphic class ii mhc allopeptides |
Country Status (13)
Country | Link |
---|---|
US (1) | US5593698A (hu) |
EP (1) | EP0637249B1 (hu) |
JP (1) | JPH07505892A (hu) |
KR (1) | KR100275656B1 (hu) |
AT (1) | ATE205400T1 (hu) |
AU (1) | AU686101B2 (hu) |
BR (1) | BR9306345A (hu) |
CA (1) | CA2118502A1 (hu) |
DE (1) | DE69330752D1 (hu) |
HU (1) | HUT71310A (hu) |
IL (1) | IL105472A (hu) |
NO (1) | NO943967D0 (hu) |
WO (1) | WO1993020842A1 (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
US6156306A (en) * | 1994-08-17 | 2000-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pancreatic β-cells for allogeneic transplantation without immunosuppression |
GB9505784D0 (en) * | 1995-03-22 | 1995-05-10 | Lynxvale Ltd | Anti-tumour treatment |
US7361331B2 (en) * | 1996-10-18 | 2008-04-22 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Plant bioreactors |
US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
US6599710B1 (en) | 1999-03-10 | 2003-07-29 | The General Hospital Corporation | Treatment of autoimmune disease |
US7348005B2 (en) * | 2000-03-15 | 2008-03-25 | Advanced Research And Technology Institute | Oral tolerance induction by collagen to prevent allograft rejection |
WO2001076617A2 (en) * | 2000-03-15 | 2001-10-18 | Advanced Research And Technology Institute | Oral tolerance induction by collagen to prevent allograft rejection |
EP2295067A1 (en) | 2000-05-24 | 2011-03-16 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | E-selectin for inducing immunotolerance |
KR20030062321A (ko) * | 2000-08-21 | 2003-07-23 | 아피토프 테크놀러지 (브리스톨) 리미티드 | 펩티드 선별 방법 |
US7582313B2 (en) | 2002-06-27 | 2009-09-01 | The General Hospital Corporation | Methods of organ regeneration using Hox 11-expressing pluripotent cells |
US7628988B2 (en) | 2002-06-27 | 2009-12-08 | The General Hospital Corporation | Methods and compositions for treating type 1 diabetes |
WO2004045376A2 (en) * | 2002-11-15 | 2004-06-03 | The General Hospital Corporation | Screening methods to identify treatments for autoimmune disease |
US20080102054A1 (en) * | 2005-01-18 | 2008-05-01 | Faustman Denise L | Compositions Containing Agm Cells And Methods Of Use Thereof |
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
CA2696563A1 (en) | 2007-08-15 | 2009-02-19 | Circassia Limited | Peptides for vaccine |
EP3936137A1 (en) | 2013-02-07 | 2022-01-12 | The General Hospital Corporation | Methods for expansion or depletion of t-regulatory cells |
JP2017516752A (ja) * | 2014-04-01 | 2017-06-22 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 単離されたドナーmhc由来ペプチド及びその使用 |
AU2016263198C1 (en) | 2015-05-15 | 2023-10-05 | The General Hospital Corporation | Antagonistic anti-tumor necrosis factor receptor superfamily antibodies |
US11266730B2 (en) | 2015-09-29 | 2022-03-08 | The General Hospital Corporation | Methods of treating and diagnosing disease using biomarkers for BCG therapy |
KR20240095471A (ko) | 2016-05-13 | 2024-06-25 | 더 제너럴 하스피탈 코포레이션 | 길항성 항-종양 괴사 인자 수용체 슈퍼패밀리 항체 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364762A (en) * | 1990-03-21 | 1994-11-15 | Board Of Trustees Of The Leland Stanford Junior University | Major histocompatibility complex (MHC) molecules |
-
1993
- 1993-03-05 US US08/027,127 patent/US5593698A/en not_active Expired - Fee Related
- 1993-04-20 AT AT93910671T patent/ATE205400T1/de not_active IP Right Cessation
- 1993-04-20 DE DE69330752T patent/DE69330752D1/de not_active Expired - Lifetime
- 1993-04-20 JP JP5518673A patent/JPH07505892A/ja not_active Ceased
- 1993-04-20 KR KR1019940703715A patent/KR100275656B1/ko not_active IP Right Cessation
- 1993-04-20 CA CA002118502A patent/CA2118502A1/en not_active Abandoned
- 1993-04-20 EP EP93910671A patent/EP0637249B1/en not_active Expired - Lifetime
- 1993-04-20 HU HU9403006A patent/HUT71310A/hu unknown
- 1993-04-20 BR BR9306345A patent/BR9306345A/pt not_active Application Discontinuation
- 1993-04-20 AU AU41083/93A patent/AU686101B2/en not_active Ceased
- 1993-04-20 WO PCT/US1993/003708 patent/WO1993020842A1/en active IP Right Grant
- 1993-04-20 IL IL10547293A patent/IL105472A/en not_active IP Right Cessation
-
1994
- 1994-10-19 NO NO943967A patent/NO943967D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU686101B2 (en) | 1998-02-05 |
JPH07505892A (ja) | 1995-06-29 |
KR100275656B1 (ko) | 2000-12-15 |
EP0637249A4 (en) | 1997-01-08 |
CA2118502A1 (en) | 1993-10-28 |
NO943967L (no) | 1994-10-19 |
WO1993020842A1 (en) | 1993-10-28 |
KR950701228A (ko) | 1995-03-23 |
DE69330752D1 (de) | 2001-10-18 |
IL105472A (en) | 1999-06-20 |
AU4108393A (en) | 1993-11-18 |
EP0637249B1 (en) | 2001-09-12 |
ATE205400T1 (de) | 2001-09-15 |
BR9306345A (pt) | 1998-06-30 |
US5593698A (en) | 1997-01-14 |
IL105472A0 (en) | 1993-08-18 |
EP0637249A1 (en) | 1995-02-08 |
NO943967D0 (no) | 1994-10-19 |
HU9403006D0 (en) | 1994-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT71310A (en) | Methods and preparations for suppression of proliferative response and induction of tolerance wita polymorphic class ii mhc allopeptides | |
Müller et al. | Microtubule-depolymerizing agents used in antibody–drug conjugates induce antitumor immunity by stimulation of dendritic cells | |
PT735893E (pt) | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária | |
KR970706013A (ko) | 암에 대해 면역학적 치료활성이 있는 스트레스 단백질-펩티드 복합체 (immunotherapeutic stress protein-peptide complexes against cancer) | |
AU7980794A (en) | Methods and compositions for microencapsulation of antigens for use as vaccines | |
Pape et al. | Characterization of Cytolytic Effector Cells in Peripheral Blood of Healthy Individuals and Cancer Patients: II. Cytotoxicity to Allogeneic or Autochthonous Tumor Cells in Tissue Culture | |
WO1998033527A3 (en) | Cancer immunotherapy with semi-allogeneic cells | |
GR3034964T3 (en) | Lymphocyte activity regulation by hla peptides. | |
CA2093513A1 (en) | Methods and compositions for suppressing allograft rejection in mammals | |
WO1999003976A3 (en) | Method of treating leukocytes, leukocyte compositions and methods of use thereof | |
ES2087163T3 (es) | Preparacion antitumoral que comprende intreleucina-2 e histamina, analogo al de las mismas o agonistas de receptor h2. | |
Golstein et al. | Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: A caveat for the interpretation of experiments done under “syngeneic” conditions | |
EP0753005A4 (en) | REGULATION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY BY CLASS I MHC PEPTIDES | |
LaCelle et al. | Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy | |
Oluwole et al. | Induction of Peripheral Tolerance by Intrathymic Inoculation of Soluble Alloantigens: Evidence for the Role of Host Antigen-Presenting Cells and Suppresser Cell Mechanism | |
NZ505834A (en) | Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use | |
GR3027668T3 (en) | Immunosuppressive compositions | |
Schechter et al. | Enhancing lymphocytes in spleens of tumor‐bearing mice: affinity chromatography on insolubilized histamine | |
Markmann et al. | Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts | |
Chen et al. | Splenic immune effector and suppressor cells in mice bearing a growing plasmacytoma | |
Paranjpe et al. | Discussion paper: specific paralysis of the antitumor cellular immune response produced by growing tumors studied with a radioisotope footpad assay | |
HK1021318A1 (en) | Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation | |
Tsokos et al. | Concanavalin-induced suppressor cells: characterization on the basis of corticosteroid and radiation sensitivity. | |
van Lochern et al. | Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone | |
Hassan et al. | Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC4 | Cancellation of temporary protection due to refusal |